Seres Therapeutics Q3 2025 Earnings Preview
Source: SeekingAlpha
2025-11-04 11:42:44 ET
More on Seres Therapeutics
- Seres Therapeutics, Inc. 2025 Q2 - Results - Earnings Call Presentation
- Seres Therapeutics, Inc. (MCRB) Q2 2025 Earnings Call Transcript
- Seres Therapeutics cuts 25% of workforce to extend cash runway into Q2 2026
- Biggest stock movers Monday: RAPP, MCRB, SATS, QS, SMMT and more
- Seeking Alpha’s Quant Rating on Seres Therapeutics
Read the full article on Seeking Alpha
For further details see:
Seres Therapeutics Q3 2025 Earnings Preview
Seres Therapeutics Inc.
NASDAQ: MCRB
MCRB Trading
2.3% G/L:
$8.89 Last:
1,664 Volume:
$8.75 Open:
MCRB Latest News
March 12, 2026 07:00:00 am
Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
MCRB Stock Data
$129,727,082
7,418,146
0.38%
16
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
